Selbyville, Delaware, Jan. 22, 2025 (GLOBE NEWSWIRE) --
Shingles vaccine market size was valued at USD 4.9 billion in 2024 and is projected to grow at a robust CAGR of 10.1% from 2025 to 2034. Key factors driving this growth include the increasing aging population, improved reimbursement frameworks, and heightened awareness about shingles prevention and complications.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/12360
Efforts to educate the public about shingles risks, particularly among older adults, have significantly boosted vaccine adoption. Health organizations are emphasizing the benefits of vaccination in mitigating severe complications, including chronic pain. These campaigns encourage proactive health measures, particularly among the elderly and their caregivers, further fueling the market expansion.
Public health campaigns and educational programs have significantly increased awareness of the risks posed by shingles, especially among older adults. Health organizations are proactively highlighting the importance of vaccination in preventing the disease and minimizing the chances of chronic pain. Consequently, a growing number of elderly individuals and their caregivers are choosing vaccination as a preventive healthcare step, driving the expansion of the market.
The shingles vaccine market is segmented by product into Shingrix, Zostavax, and SKYZoster, with Shingrix leading the market by generating USD 4.2 billion in revenue in 2023. Its recombinant formulation provides durable and effective protection, particularly for high-risk groups such as older adults. The vaccine’s long-lasting immunity reduces the need for frequent boosters, enhancing its appeal as a cost-effective and reliable option.
By vaccine type, the shingles vaccine market is categorized into recombinant and live attenuated vaccines. The recombinant vaccine segment dominated in 2023 and is forecasted to reach USD 11.3 billion by 2032. These vaccines demonstrate superior efficacy, offering 90% protection even among vulnerable populations. Their extended immunity duration eliminates the need for repeated doses, making them the preferred choice over live attenuated options.
North America shingles vaccine market generated USD 2.7 billion in 2023. This dominance is driven by high awareness levels, supportive healthcare policies, and strong public health advocacy. Recommendations for shingles vaccination for adults aged 50 and older have been widely adopted, supported by accessible insurance coverage through Medicare and private insurers. The aging demographic and proactive health initiatives further strengthen the region's market position.
Request for Report Customization @ https://www.gminsights.com/roc/12360
Major players in shingles vaccine market include GSK plc., Merck & Co., and SK bioscience among others.
Partial Table of Contents (ToC) of the report:
Methodology and Scope
1.1. Market scope and definitions
1.2. Research design
1.2.1. Research approach
1.2.2. Data collection methods
1.3. Base estimates and calculations
1.3.1. Base year calculation
1.3.2. Key trends for market estimation
1.4. Forecast model
1.5. Primary research and validation
1.5.1. Primary sources
1.5.2. Data mining sources
Chapter 2. Executive Summary
2.1. Industry 3600 synopsis
Chapter 3. Industry Insights
3.1. Industry ecosystem analysis
3.2. Industry impact forces
3.2.1. Growth drivers
3.2.1.1. Rising geriatric population
3.2.1.2. Advancements in vaccine development
3.2.1.3. Favourable reimbursement policies
3.2.1.4. Growing awareness about shingles and its complications
3.2.2. Industry pitfalls and challenges
3.2.2.1. Stringent regulatory requirements
3.3. Growth potential analysis
3.4. Regulatory landscape
3.5. Pricing analysis, 2023
3.6. Pipeline analysis
3.7. Technology landscape
3.8. Future market trends
3.9. Gap analysis
3.10. Porter’s analysis
3.11. PESTEL analysis
Browse more vaccines industry reports @ https://www.gminsights.com/industry-reports/vaccines/82
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
